180 Wealth Advisors LLC bought a new stake in UnitedHealth Group Inc (NYSE:UNH) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 1,662 shares of the healthcare conglomerate’s stock, valued at approximately $355,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Exane Derivatives increased its holdings in shares of UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares during the period. Aevitas Wealth Management Inc. bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $102,000. Bamco Inc. NY bought a new stake in UnitedHealth Group during the first quarter worth approximately $117,000. Pathstone Family Office LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $129,000. Finally, Trustcore Financial Services LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $133,000. 84.94% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Larry C. Renfro sold 19,652 shares of the firm’s stock in a transaction on Friday, June 15th. The stock was sold at an average price of $254.55, for a total value of $5,002,416.60. Following the completion of the sale, the insider now directly owns 153,679 shares in the company, valued at $39,118,989.45. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kenneth Irwin Shine sold 202 shares of the firm’s stock in a transaction on Thursday, April 19th. The shares were sold at an average price of $237.42, for a total value of $47,958.84. Following the completion of the sale, the director now owns 28,948 shares of the company’s stock, valued at $6,872,834.16. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 49,854 shares of company stock valued at $12,295,675. 0.87% of the stock is currently owned by corporate insiders.
A number of brokerages have issued reports on UNH. BMO Capital Markets upped their target price on UnitedHealth Group from $285.00 to $300.00 and gave the stock a “positive” rating in a research report on Thursday, June 21st. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 19th. SunTrust Banks started coverage on UnitedHealth Group in a research report on Monday, June 11th. They issued a “buy” rating and a $300.00 price objective for the company. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Wednesday, May 2nd. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $270.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 18th. One analyst has rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $263.00.
UnitedHealth Group stock opened at $247.48 on Tuesday. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.71 and a quick ratio of 0.71. UnitedHealth Group Inc has a 52-week low of $183.86 and a 52-week high of $256.73. The firm has a market cap of $235.77 billion, a price-to-earnings ratio of 24.42, a P/E/G ratio of 1.41 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 17th. The healthcare conglomerate reported $3.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.91 by $0.13. UnitedHealth Group had a return on equity of 22.06% and a net margin of 5.41%. The firm had revenue of $55.19 billion during the quarter, compared to analyst estimates of $54.90 billion. During the same period in the prior year, the company posted $2.37 earnings per share. The business’s revenue for the quarter was up 13.3% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Inc will post 12.62 EPS for the current fiscal year.
UnitedHealth Group announced that its Board of Directors has authorized a share buyback plan on Wednesday, June 6th that allows the company to repurchase 100,000,000 shares. This repurchase authorization allows the healthcare conglomerate to purchase shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its stock is undervalued.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 26th. Stockholders of record on Monday, June 18th were paid a $0.90 dividend. The ex-dividend date of this dividend was Friday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.75. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.75%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.